INBS
Intelligent Bio Solutions Inc.
Price Chart
Latest Quote
$2.14
-0.06 (-2.55%)
Current Price
| Previous Close | $2.20 |
| Open | $2.19 |
| Day High | $2.29 |
| Day Low | $2.10 |
| Volume | 21,508 |
Stock Information
| Shares Outstanding | 2.39M |
| Total Debt | $1.85M |
| Cash Equivalents | $6.86M |
| Revenue | $3.91M |
| Net Income | $-11.61M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $5.13M |
| EPS (TTM) | $-11.62 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $38K |
| Sales | $3.91M |
| Income | $-11.61M |
| Book/sh | $4.48 |
| Cash/sh | $2.87 |
| Employees | 53 |
Financial Ratios
| Quick Ratio | 1.80 |
| Current Ratio | 2.11 |
| Debt/Eq | 21.12 |
Returns & Margins
| ROA | -57.25% |
| ROE | -170.19% |
| Gross Margin | 47.25% |
| Operating Margin | -277.33% |
| Profit Margin | -296.77% |
Ownership
| Insider Ownership | 3.57% |
| Institutional Ownership | 8.71% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 6.13 |
| P/S | 1.31 |
| P/B | 0.48 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.38 |
| SMA50 | $2.64 |
| SMA200 | $6.66 |
| RSI | 27.93 |
| ATR | 0.1515 |
| Shares Float | 2.17M |
| Short Float | 3.83% |
| Short Ratio | 0.52 |
| Volatility | 4.18 |
| Rel Volume | 0.34 |
Performance History
| Week | -4.72% |
| Month | -19.10% |
| Quarter | -36.00% |
| 6 Months | -62.71% |
| YTD | -72.83% |
| Year | -87.96% |
| 3 Years | -99.38% |
| 5 Years | -99.98% |
| 10 Years | -99.99% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $2.14 | 21,508 |
| 2026-06-24 | $2.20 | 65,900 |
| 2026-06-23 | $2.30 | 28,900 |
| 2026-06-22 | $2.38 | 18,900 |
| 2026-06-18 | $2.29 | 64,200 |
| 2026-06-17 | $2.25 | 34,400 |
| 2026-06-16 | $2.30 | 80,100 |
| 2026-06-15 | $2.33 | 61,100 |
| 2026-06-12 | $2.40 | 22,500 |
| 2026-06-11 | $2.39 | 50,400 |
| 2026-06-10 | $2.35 | 21,100 |
| 2026-06-09 | $2.42 | 39,400 |
| 2026-06-08 | $2.40 | 205,500 |
| 2026-06-05 | $2.45 | 115,600 |
| 2026-06-04 | $2.46 | 58,900 |
| 2026-06-03 | $2.44 | 72,500 |
| 2026-06-02 | $2.54 | 58,200 |
| 2026-06-01 | $2.48 | 59,200 |
| 2026-05-29 | $2.57 | 49,200 |
| 2026-05-28 | $2.52 | 149,600 |
| 2026-05-27 | $2.49 | 95,700 |
| 2026-05-26 | $2.65 | 116,000 |
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
đ° Latest News
Top Midday Decliners
MT Newswires âĸ 2026-01-02T18:14:54ZBC-Most Active Stocks
Associated Press Finance âĸ 2025-12-31T15:30:17ZIntelligent Bio Solutions Full Year 2025 Earnings: US$2.00 loss per share (vs US$6.38 loss in FY 2024)
Simply Wall St. âĸ 2025-08-17T12:41:28Z
EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4
Benzinga âĸ 2025-08-07T14:01:56Z
EXCLUSIVE: Intelligent Bio Solutions' New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro Level
Benzinga âĸ 2025-07-23T12:03:20Z
EXCLUSIVE: Intelligent Bio Targets Global Market With Distribution Pact For Sweat-Based Drug Detection Patch
Benzinga âĸ 2025-07-16T12:03:02Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,799,799 | $1,674,344 | $930,204 | $0 |
| Cost Of Revenue | $1,805,673 | $1,686,155 | $930,204 | $0 |
| Total Revenue | $3,052,532 | $3,111,781 | $1,256,872 | $0 |
| Operating Revenue | $3,052,532 | $3,111,781 | $1,256,872 | $0 |
| Expenses | ||||
| Interest Expense | $60,890 | $167,140 | $223,534 | $7,539 |
| Total Expenses | $13,477,077 | $13,394,955 | $9,693,435 | $8,336,876 |
| Other Income Expense | $-220,973 | $174,560 | $-2,014,134 | $-3,987 |
| Net Non Operating Interest Income Expense | $40,632 | $-82,318 | $-213,858 | $6,887 |
| Interest Expense Non Operating | $60,890 | $167,140 | $223,534 | $7,539 |
| Operating Expense | $11,671,404 | $11,708,800 | $8,763,231 | $8,336,876 |
| Other Operating Expenses | $-816,901 | $-424,776 | $-737,628 | $-437,146 |
| General And Administrative Expense | - | - | - | $4,920,103 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-10,568,733 | $-10,156,759 | $-10,631,720 | $-8,306,051 |
| Net Interest Income | $40,632 | $-82,318 | $-213,858 | $6,887 |
| Interest Income | $101,522 | $84,822 | $9,676 | $14,426 |
| Normalized Income | $-10,347,760 | $-10,331,319 | $-8,617,586 | $-8,302,064 |
| Net Income From Continuing And Discontinued Operation | $-10,568,733 | $-10,156,759 | $-10,631,720 | $-8,306,051 |
| Total Operating Income As Reported | $-10,644,607 | $-10,283,174 | $-12,595,233 | $-8,336,876 |
| Net Income Common Stockholders | $-10,568,733 | $-10,156,759 | $-10,631,720 | $-8,306,051 |
| Net Income | $-10,568,733 | $-10,156,759 | $-10,631,720 | $-8,306,051 |
| Net Income Including Noncontrolling Interests | $-10,604,886 | $-10,190,932 | $-10,664,555 | $-8,333,976 |
| Net Income Continuous Operations | $-10,604,886 | $-10,190,932 | $-10,664,555 | $-8,333,976 |
| Pretax Income | $-10,604,886 | $-10,190,932 | $-10,664,555 | $-8,333,976 |
| Special Income Charges | $-220,062 | $0 | $-4,158,670 | $0 |
| Interest Income Non Operating | $101,522 | $84,822 | $9,676 | $14,426 |
| Operating Income | $-10,424,545 | $-10,283,174 | $-8,436,563 | $-8,336,876 |
| Depreciation Amortization Depletion Income Statement | $1,207,875 | $1,201,274 | $966,732 | $0 |
| Depreciation And Amortization In Income Statement | $1,207,875 | $1,201,274 | $966,732 | $0 |
| Gross Profit | $1,246,859 | $1,425,626 | $326,668 | $0 |
| Earnings From Equity Interest | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-20.00 | $-63.80 | $-1270.00 | $-1368.00 |
| Basic EPS | $-20.00 | $-63.80 | $-1270.00 | $-1368.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,109,274 | $-8,985,267 | $-7,460,155 | $-8,322,450 |
| Total Unusual Items | $-220,973 | $174,560 | $-2,014,134 | $-3,987 |
| Total Unusual Items Excluding Goodwill | $-220,973 | $174,560 | $-2,014,134 | $-3,987 |
| Reconciled Depreciation | $1,213,749 | $1,213,085 | $966,732 | $0 |
| EBITDA (Bullshit earnings) | $-9,330,247 | $-8,810,707 | $-9,474,289 | $-8,326,437 |
| EBIT | $-10,543,996 | $-10,023,792 | $-10,441,021 | $-8,326,437 |
| Diluted Average Shares | $527,364 | $159,274 | $8,371 | $6,110 |
| Basic Average Shares | $527,364 | $159,274 | $8,371 | $6,110 |
| Diluted NI Availto Com Stockholders | $-10,568,733 | $-10,156,759 | $-10,631,720 | $-8,306,051 |
| Minority Interests | $36,153 | $34,173 | $32,835 | $27,925 |
| Impairment Of Capital Assets | $220,062 | $0 | $4,158,670 | $0 |
| Gain On Sale Of Security | $-911 | $174,560 | $2,144,536 | $-3,987 |
| Research And Development | $2,396,513 | $1,673,806 | $507,424 | $3,853,919 |
| Selling General And Administration | $8,883,917 | $9,258,496 | $8,026,703 | $4,920,103 |
| Other Gand A | - | - | - | $4,920,103 |
| Tax Provision | - | - | - | - |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-794,183 | $3,957,324 | $-1,456,417 | $6,624,922 |
| Total Assets | $8,249,786 | $13,778,863 | $10,354,612 | $12,352,173 |
| Total Non Current Assets | $4,111,164 | $5,244,620 | $6,492,051 | $1,484,181 |
| Goodwill And Other Intangible Assets | $3,790,319 | $4,372,026 | $5,255,401 | $0 |
| Other Intangible Assets | $3,790,319 | $4,372,026 | $5,255,401 | - |
| Current Assets | $4,138,622 | $8,534,243 | $3,862,561 | $10,867,992 |
| Assets Held For Sale Current | $327,500 | $0 | - | - |
| Current Deferred Assets | $67,160 | $0 | $34,100 | $0 |
| Prepaid Assets | $489,729 | $474,260 | $478,146 | $163,127 |
| Inventory | $635,215 | $777,537 | $979,907 | $0 |
| Receivables | $1,599,109 | $978,348 | $833,164 | $2,466,564 |
| Other Receivables | $19,999 | $6,301 | $20,127 | $1,555,325 |
| Taxes Receivable | $984,496 | $542,343 | $519,176 | $410,794 |
| Accounts Receivable | $594,614 | $429,704 | $293,861 | $0 |
| Allowance For Doubtful Accounts Receivable | $-546 | $-6,772 | - | - |
| Gross Accounts Receivable | $595,160 | $436,476 | - | - |
| Cash Cash Equivalents And Short Term Investments | $1,019,909 | $6,304,098 | $1,537,244 | $8,238,301 |
| Cash And Cash Equivalents | $1,019,909 | $6,304,098 | $1,537,244 | $8,238,301 |
| Cash Financial | $1,019,909 | $6,304,098 | $1,537,244 | - |
| Notes Receivable | - | - | $0 | $500,445 |
| Non Current Accounts Receivable | - | - | - | $1,092,773 |
| Other Non Current Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $281,805 | $871,440 | $1,335,685 | $0 |
| Long Term Debt And Capital Lease Obligation | $0 | $81,324 | $759,027 | $0 |
| Current Debt And Capital Lease Obligation | $281,805 | $790,116 | $576,658 | - |
| Current Debt | $197,146 | $515,282 | $353,211 | - |
| Other Current Borrowings | - | $515,282 | $353,211 | - |
| Long Term Debt | - | - | $402,862 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $5,435,962 | $5,595,672 | $6,667,614 | $5,806,402 |
| Total Non Current Liabilities Net Minority Interest | $84,921 | $144,939 | $783,929 | $1,143,399 |
| Current Liabilities | $5,351,041 | $5,450,733 | $5,883,685 | $4,663,003 |
| Current Deferred Liabilities | $2,172,108 | $2,486,668 | $2,546,557 | $2,836,582 |
| Current Notes Payable | $197,146 | $515,282 | - | - |
| Payables And Accrued Expenses | $2,362,138 | $1,704,568 | $2,401,528 | $1,625,089 |
| Payables | $1,172,280 | $1,097,392 | $1,196,222 | $715,902 |
| Total Tax Payable | $84,806 | $50,283 | $0 | - |
| Accounts Payable | $897,258 | $602,337 | $1,196,222 | $715,902 |
| Non Current Deferred Liabilities | - | - | $0 | $1,092,773 |
| Other Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $2,996,136 | $8,329,350 | $3,798,984 | $6,624,922 |
| Total Equity Gross Minority Interest | $2,813,824 | $8,183,191 | $3,686,998 | $6,545,771 |
| Stockholders Equity | $2,996,136 | $8,329,350 | $3,798,984 | $6,624,922 |
| Gains Losses Not Affecting Retained Earnings | $-327,944 | $-712,614 | $-575,496 | $-788,135 |
| Other Equity Adjustments | $-327,944 | $-712,614 | $-575,496 | $-788,135 |
| Retained Earnings | $-62,533,065 | $-51,964,332 | $-41,807,573 | $-31,175,853 |
| Preferred Stock Equity | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $11 | $11 | $11 | - |
| Ordinary Shares Number | $732,326 | $345,588 | $19,408 | $6,204 |
| Share Issued | $732,337 | $345,599 | $19,419 | $6,204 |
| Tangible Book Value | $-794,183 | $3,957,324 | $-1,456,417 | $6,624,922 |
| Invested Capital | $3,193,282 | $8,844,632 | $4,555,057 | $6,624,922 |
| Working Capital | $-1,212,419 | $3,083,510 | $-2,021,124 | $6,204,989 |
| Capital Lease Obligations | $84,659 | $356,158 | $579,612 | $0 |
| Total Capitalization | $2,996,136 | $8,329,350 | $4,201,846 | $6,624,922 |
| Minority Interest | $-182,312 | $-146,159 | $-111,986 | $-79,151 |
| Treasury Stock | $1 | $1 | $1 | $0 |
| Additional Paid In Capital | $65,783,916 | $60,971,740 | $46,180,112 | $38,581,465 |
| Capital Stock | $73,230 | $34,557 | $1,942 | $7,445 |
| Common Stock | $73,230 | $34,557 | $1,942 | $7,445 |
| Employee Benefits | $84,921 | $63,615 | $24,902 | $50,626 |
| Long Term Capital Lease Obligation | $0 | $81,324 | $356,165 | $0 |
| Current Deferred Revenue | $2,172,108 | $2,486,668 | $2,338,057 | $2,836,582 |
| Current Capital Lease Obligation | $84,659 | $274,834 | $223,447 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $534,990 | $469,381 | $358,942 | $201,332 |
| Current Accrued Expenses | $1,189,858 | $607,176 | $1,205,306 | $909,187 |
| Dueto Related Parties Current | $190,216 | $444,772 | - | $0 |
| Net PPE | $320,845 | $872,594 | $1,236,650 | $391,408 |
| Accumulated Depreciation | $-88,164 | $-60,775 | $-33,769 | $0 |
| Gross PPE | $409,009 | $933,369 | $1,270,419 | $391,408 |
| Leases | $21,818 | $20,074 | $20,069 | $0 |
| Construction In Progress | $0 | $543,410 | $646,116 | $391,408 |
| Other Properties | $151,078 | $369,885 | $604,234 | - |
| Machinery Furniture Equipment | $236,113 | $0 | - | - |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $430,132 | $588,844 | $757,518 | $0 |
| Work In Process | $205,083 | $188,693 | - | - |
| Inventories Adjustments Allowances | - | $0 | $-197,500 | $0 |
| Raw Materials | - | $188,693 | $419,889 | $0 |
| Preferred Stock | - | - | $0 | $0 |
| Non Current Deferred Revenue | - | - | $0 | $1,092,773 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-9,909,151 | $-9,792,995 | $-7,882,501 | $-3,738,255 |
| Operating Activities | ||||
| Operating Cash Flow | $-9,677,313 | $-9,571,569 | $-7,377,378 | $-3,358,034 |
| Cash Flow From Continuing Operating Activities | $-9,677,313 | $-9,571,569 | $-7,377,378 | $-3,358,034 |
| Operating Gains Losses | - | $1,178 | $9,829 | $-3,987 |
| Investing Activities | ||||
| Capital Expenditure | $-231,838 | $-221,426 | $-505,123 | $-380,221 |
| Investing Cash Flow | $-231,838 | $-221,426 | $-694,142 | $-880,221 |
| Cash Flow From Continuing Investing Activities | $-231,838 | $-221,426 | $-694,142 | $-880,221 |
| Net Other Investing Changes | - | - | - | $-500,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $4,589,866 | $12,903,745 | $2,775,041 | $0 |
| Financing Cash Flow | $4,597,805 | $14,560,556 | $1,435,323 | $0 |
| Cash Flow From Continuing Financing Activities | $4,597,805 | $14,560,556 | $1,435,323 | $0 |
| Net Common Stock Issuance | $4,589,866 | $12,903,745 | $2,554,463 | $0 |
| Common Stock Issuance | $4,589,866 | $12,903,745 | $2,554,463 | $0 |
| Net Preferred Stock Issuance | - | $0 | $220,578 | $0 |
| Preferred Stock Issuance | - | $0 | $220,578 | $0 |
| Net Other Financing Charges | - | - | $-1,339,718 | - |
| Other | ||||
| End Cash Position | $1,019,909 | $6,304,098 | $1,537,244 | $8,238,301 |
| Beginning Cash Position | $6,304,098 | $1,537,244 | $8,238,301 | $12,573,685 |
| Effect Of Exchange Rate Changes | $27,157 | $-707 | $-64,860 | $-97,129 |
| Changes In Cash | $-5,311,346 | $4,767,561 | $-6,636,197 | $-4,238,255 |
| Proceeds From Stock Option Exercised | $7,939 | $1,656,811 | $0 | $0 |
| Net PPE Purchase And Sale | $-231,838 | $-221,426 | $-505,123 | $-380,221 |
| Purchase Of PPE | $-231,838 | $-221,426 | $-505,123 | $-380,221 |
| Change In Working Capital | $-720,778 | $-701,929 | $78,917 | $2,439,066 |
| Change In Other Working Capital | $21,306 | $-364,149 | - | - |
| Change In Other Current Liabilities | $-271,499 | $51,387 | $-133,646 | $28,856 |
| Change In Other Current Assets | $-329,404 | $55,219 | $-118,335 | $-333,743 |
| Change In Payables And Accrued Expense | $2,577,151 | $-632,950 | $84,502 | $242,655 |
| Change In Inventory | $142,322 | $202,370 | $-345,390 | $0 |
| Change In Receivables | $-2,860,654 | $-13,806 | $591,786 | $2,501,298 |
| Changes In Account Receivables | $-164,910 | $-135,843 | $-293,861 | $0 |
| Other Non Cash Items | $-24,051 | $-24,177 | $-222,276 | $2,540,863 |
| Stock Based Compensation | $238,045 | $230,496 | $260,000 | $0 |
| Unrealized Gain Loss On Investment Securities | $0 | $-175,738 | $-2,154,365 | $0 |
| Provisionand Write Offof Assets | $546 | $6,772 | $189,670 | $0 |
| Asset Impairment Charge | $220,062 | $69,676 | $4,158,670 | $0 |
| Depreciation Amortization Depletion | $1,213,749 | $1,213,085 | $966,732 | $0 |
| Depreciation And Amortization | $1,213,749 | $1,213,085 | $966,732 | $0 |
| Depreciation | $1,213,749 | $1,213,085 | $966,732 | $0 |
| Net Foreign Currency Exchange Gain Loss | $0 | $1,178 | $9,829 | $-3,987 |
| Net Income From Continuing Operations | $-10,604,886 | $-10,190,932 | $-10,664,555 | $-8,333,976 |
| Net Business Purchase And Sale | - | $0 | $-189,019 | $0 |
| Sale Of Business | - | $0 | $174,481 | $0 |
| Purchase Of Business | - | $0 | $-363,500 | $0 |
| Change In Payable | - | $-632,950 | $84,502 | $242,655 |
| Change In Account Payable | - | $-632,950 | $84,502 | $242,655 |
| Net Investment Purchase And Sale | - | - | $0 | $-500,000 |
| Purchase Of Investment | - | - | $0 | $-500,000 |
| Interest Paid Supplemental Data | - | - | - | $0 |
| Earnings Losses From Equity Investments | - | - | - | $0 |
Fetched: 2026-06-22